Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : ARIAD Pharmaceuticals -- Ignore unavailable to you. Want to Upgrade?

To: scott_jiminez who wrote (1204)	6/4/2000 10:33:00 AM
From: scott_jiminez	Read Replies (1) \| Respond to of 4474

Ariad at ASGT Ariad's GVHD data was included in a press release of studies showing 'significant progress in efforts to combat genetic disorders using gene therapies.' The press release asgt.org ASGT home page asgt.org The abstract and link - A New Humanized Fas Receptor-Based Suicide Strategy for the Induction of Controlled Graft-versus-tumor Effect after Allogeneic Marrow Transplantation. Sarah Marktel, Daniel Thomis, Catia Traversari, Chiara Bonini, Zulma Magnani, Michael Gilman, C Bordignon, Tim Clackson Telethon Institute for Gene Therapy (TIGET), Istituto Scientifico H.S.Raffaele, Milano, Italy; ARIAD Gene Therapeutics, Cambridge, MA The abstract apnet.com ------------------------- Ariad's other presentations - 1. Regulated Insulin Gene Delivery for Treatment of Type I Diabetes. A Auricchio, GP Gao, P Zoltick, A Shifrin, S Raper, V Rivera, JM Wilson Institute for Human Gene Therapy, The Wistar Institute, Depts. of Cellular and Molecular Engineering and Dept. of Surgery, University of Pennsylvania, Philadelphia, PA; Ariad Pharmaceuticals, Cambridge, MA Abstract apnet.com 2. Regulated Feline Erythropoietin Expression with an Adeno-associated Viral Vector System in Cats. Michael A. Schnell, Philip Zoltick, Tim Clackson, Vic Rivera, Gary Kurtzman, Urs Giger, James M. Wilson Institute for Human Gene Therapy and Department of Molecular Cellular Engineering (School of Medicine), University of Pennsylvania; ARIAD Pharmaceuticals; Genovo, Inc.; Department of Clinical Studies (School of Veterinary Medicine), University of Pennsylvania, Philadelphia, Pennsylvania Abstract apnet.com 3. Pharmacologic Regulated Expression in the Systemic Delivery of Erythropoietin Following Skeletal Muscle Transduction with rAAV Vectors in Non-Human Primates. P. Zoltick, M. Schnell, N. Chirmule, G. Kurtzman, V. Rivera, T. Clackson, J. Wilson Institute for Human Gene Therapy, University of Pennsylvania, Philadelphia, Pennsylvania; ARIAD Gene Therapeutics Inc., Cambridge, Massachusetts Abstract apnet.com --------------------- Not sure what to make of this ongoing collaboration with Wilson. I'll comment soon on the data here...suffice to say, quite impressive progress. I need to check if the previous 'fail-safe' mechanism was humanized. If not, this is indeed 'new'...and sweet.